Polomar Health Services, Inc.
PMHS
Rank in Stocks
#31183
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The... Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Beckerโs nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Share Price
$0.12504
Last synced: 2026-11-10
Market Cap
$3.51M
Change (1 day)
-33.31%
Change (1 year)
-37.48%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Polomar Health Services, Inc. (PMHS)
Category
Healthcare
EPS for Polomar Health Services, Inc. (PMHS)
EPS as of June 2026 TTM: $-0.35
According to Polomar Health Services, Inc.'s latest financial reports, its current EPS (TTM) is $-0.35. At the end of 2025 the company had an EPS of $-0.39, a decrease compared to its 2024 EPS of $-0.05.
EPS history for Polomar Health Services, Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.35 | -10.26% |
| 2025 | $-0.39 | 680.00% |
| 2024 | $-0.05 | 1,215.79% |
| 2023 | 0.00 | 850.00% |
| 2022 | 0.00 | -99.93% |
| 2021 | $-0.54 | -268.75% |
| 2019 | $0.32 | -206.67% |
| 2018 | $-0.30 | 36.36% |
| 2009 | $-0.22 | -40.54% |
| 2008 | $-0.37 | 208.33% |
| 2007 | $-0.12 | -62.50% |
| 2006 | $-0.32 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | -8,748.57% |
US
|
|
| $3.19 | -1,011.26% |
DE
|
|
| $34.71 | -10,017.14% |
US
|
|
| $1.90 | -643.49% |
SA
|
|
| $0.29 | -182.29% |
CN
|
Questions about Polomar Health Services, Inc.'s earnings per share (EPS)
What is Polomar Health Services, Inc.'s earnings per share (EPS)?
Polomar Health Services, Inc.'s earnings per share (EPS) over the last twelve months is $-0.35, as of Jun 2026.
What was Polomar Health Services, Inc.'s earnings per share (EPS) in 2025?
In 2025, Polomar Health Services, Inc.'s earnings per share (EPS) was $-0.39, compared with $-0.05 in 2024.
How has Polomar Health Services, Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Polomar Health Services, Inc.'s earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2021 ($-0.54).
How does Polomar Health Services, Inc.'s earnings per share (EPS) compare with similar companies?
Polomar Health Services, Inc.'s earnings per share (EPS) ($-0.35) is lower than that of all 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.